药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Thyroglobulin
Ramiprilat
The serum concentration of Lithium carbonate can be increased when it is combined with Ramiprilat.
Thyroglobulin
Fosinoprilat
The serum concentration of Lithium carbonate can be increased when it is combined with Fosinoprilat.
Thyroglobulin
Benazeprilat
The serum concentration of Lithium carbonate can be increased when it is combined with Benazeprilat.
Thyroglobulin
Delapril
The serum concentration of Lithium carbonate can be increased when it is combined with Delapril.
Thyroglobulin
Zofenopril
The serum concentration of Lithium carbonate can be increased when it is combined with Zofenopril.
Thyroglobulin
Imidapril
The serum concentration of Lithium carbonate can be increased when it is combined with Imidapril.
Thyroglobulin
Azilsartan medoxomil
The serum concentration of Lithium carbonate can be increased when it is combined with Azilsartan medoxomil.
Thyroglobulin
Saralasin
The serum concentration of Lithium carbonate can be increased when it is combined with Saralasin.
Sulfamethazine
Sulfate ion
The risk or severity of adverse effects can be increased when Sodium phosphate, monobasic, unspecified form is combined with Sulfate ion.
Sulfamethazine
Sodium cation
The risk or severity of adverse effects can be increased when Sodium phosphate, monobasic, unspecified form is combined with Sodium cation.
Sulfamethazine
Dehydrocholic acid
The risk or severity of adverse effects can be increased when Dehydrocholic acid is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Frangula purshiana bark
The risk or severity of adverse effects can be increased when Sodium phosphate, monobasic, unspecified form is combined with Frangula purshiana bark.
Sulfamethazine
Alloin
The risk or severity of adverse effects can be increased when Sodium phosphate, monobasic, unspecified form is combined with Alloin.
Sulfamethazine
Konjac mannan
The risk or severity of adverse effects can be increased when Sodium phosphate, monobasic, unspecified form is combined with Konjac mannan.
Sulfamethazine
Emodin
The risk or severity of adverse effects can be increased when Sodium phosphate, monobasic, unspecified form is combined with Emodin.
Sulfamethazine
Calcium polycarbophil
The risk or severity of adverse effects can be increased when Sodium phosphate, monobasic, unspecified form is combined with Calcium polycarbophil.
Sulfamethazine
Oxyphenisatin acetate
The risk or severity of adverse effects can be increased when Sodium phosphate, monobasic, unspecified form is combined with Oxyphenisatin acetate.
Sulfamethazine
Magnesium
The risk or severity of adverse effects can be increased when Sodium phosphate, monobasic, unspecified form is combined with Magnesium.
Sulfamethazine
Potassium sulfate
The risk or severity of adverse effects can be increased when Potassium sulfate is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Sodium ascorbate
The risk or severity of adverse effects can be increased when Sodium ascorbate is combined with Sodium phosphate, monobasic, unspecified form.